One-third of all human cancer patients report pain (60-90% with advanced cancer).
• Cancer is often a painful disease
• ⅓ of all human cancer patients report pain (60-90% with advanced cancer)
• 70-90% can achieve "good" pain control
• In human patients, pain is often more feared than death
• extension of these same concerns by owners to their pet's cancer
• understand the disease and extent
• recognize the cause and importance of each pain
• consider diverse management options
• staged pain management approach
• titrate, adjust and balance care to maintain the most appropriate control
• surgical oncology, radiation therapy, "break-through" pain
• pain of metastasis, treatment related pain
• palliative care and terminal cancer pain
• Pain in dying, aspects of suffering and the psychology of cancer
• Pre-emptive, balanced multi-modal and adequate analgesia
• Value of local anesthetics in surgical oncology
o Injection of nerve sheath prior to transection (amputation)
• Brachial Plexus nerve block - effective distal to elbow
• History - comprehensive
• Examine sites of pain and dysfunction thoroughly (may need analgesics!)
• Use appropriate diagnostic tools: (Radiography, Ultrasound, CT, MRI, Nuclear Scintigraphy) Advanced techniques can be very helpful.
• Evaluate extent of disease - extent of pain
• Treat the pain early and aggressively to fully gain control early
• Watch for development of tolerance (specifically to opioids) and side effects (can be managed)
• associated with tumor involvement
o compression, erosion, nerve compromise
o paraneoplastic syndromes
• surgery or other procedures
• importance of operative pain management can not be overstated
o operative pain management is often the first opportunity we have
• more difficult to diagnose and to treat
• longer duration, less well defined onset
• may be associated with hypersensitivity
• may increase with tumor progression
• may subside during periods of tumor regression
• associated with a negative quality of life
• somatic, visceral, neuropathic, inflammatory
Somatic Pain in Cancer
• more acute and specific in nature
• nociceptor activation: sharp, aching, throbbing or pressure-like
• metastatic bone pain, post surgical pain, musculoskeletal pain
Visceral Pain in Cancer
• less well localized
• nociceptors of thoracic, abdominal or pelvic viscera
• diffuse gnawing or cramping, aching or throbbing
Neuropathic Pain in Cancer
• central or peripheral nerve involvement
• infiltration or compression of nerves
• phantom limb syndrome
• corticosteroids, decompression, neurolysis
Inflammatory Mediators
• "alogenic" chemical mediators
• histamine, serotonin, bradykinins, leukotrienes, prostaglandins
• NSAID's, corticosteriods
• treatment of paraneoplastic syndromes
• Prognosis, Costs, Quality of life, Willingness to treat
• Combined strategies, balanced analgesia
• surgical excision, radiation therapy, chemotherapy, immunotherapy
• relies on intensity and severity rather than mechanism and etiology
• individualized and titrated management
• escalation of analgesic strategies
• three (or four) levels of intervention:
o mild, moderate, severe, (refractory)
WHO Analgesia Ladder - Step one - Mild Pain
• NSAID's, acetaminophen
• many individual options for dogs and cats
• ± adjuvants (GI protective)
• misoprostol, H2 blockers, H+ blockers, etc.
WHO Analgesia Ladder - Step two - Moderate Pain
• NSAID's plus mild opioids, many options
• add low dose weak or partial agonist
WHO Analgesia Ladder - Step three - Severe Pain
• Stronger opioid, perhaps added to NSAID
WHO Analgesia Ladder - Step four - Refractory Pain
• alternative routes of delivery, interventions,
• blocks, neural stimulations, neurolysis
• Appetite
• Activity
• Involvement
• Function
• Hospice care
• Progression of disease
• Unmanageable pain
• Unmanageable side-effects
• Toxicities from therapy
• Concurrent diseases
• Euthanasia as a part of cancer care
o Time for a "house call"
• Often the most appreciated part of our interaction with the owners and animals
• When the time comes...
Presurgical evaluation and diagnostic imaging for canine mast cell tumors
November 7th 2024Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York
Read More